As of 2025-09-17, the Fair Value of Foghorn Therapeutics Inc. (FHTX) is -6.67 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.90 USD, the upside of Foghorn Therapeutics Inc. is -236.09%.
With the market price of 4.90 USD and our fair value calculation, Foghorn Therapeutics Inc. (FHTX) is not a good investment. Investing in FHTX stocks now will result in a potential loss of 236.09%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -68.80 | -101.32 | -108.88 | -98.43 | -86.62 | -92.81 |
| YoY growth | -34.56% | -47.27% | -7.46% | 9.60% | 11.99% | -13.54% |
| Market Cap (mil) | 277.00 |
| P/E | |
| Forward P/E |
| EPS | -1.33 |
| Avg earnings growth rate | -13.54% |
| TTM earnings | -75.39 |